Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Curis Inc.
DescriptionIV formulation of small molecule inhibitor of human epidermal growth factor receptor (EGFR), EGFR2 (HER2; ErbB2; neu) and histone deacetylase (HDAC)
Molecular Target Epidermal growth factor receptor 2 (HER2) (EGFR2) (ErbB2) (neu) ; Histone deacetylase (HDAC)
Mechanism of ActionEpidermal growth factor (EGF) receptor 2 (HER2) (ErbB2) (neu) inhibitor; Histone deacetylase (HDAC) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today